APRIL - 20236Managing EditorAlex D'souzaVisualizerChris LynnMichael WayneAPRIL - 24 - 2023, volume 06 - Issue 09 (ISSN 2691-4093) Published by ValleyMedia, Inc. Emailsales@medicaltechoutlook.comeditor@medicaltechoutlook.commarketing@medicaltechoutlook.comTo subscribe to Medical Tech OutlookVisit www.medicaltechoutlook.com Copyright © 2023 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffAlex D'souzaManaging Editoreditor@medicaltechoutlook.comAs AI and machine learning techniques impact biomedical research, they are providing the new potential to boost drug delivery systems. AI acts as a robust tool to establish structure-function relationships between formulation parameters and release kinetics and helps tune a drug delivery system for optimal performance. For instance, a cascade computer model is designed to predict drug diffusivity from different mucoadhesive formulations. AI, in this regard, can aid in drug discovery, repurposing, side effect prediction, and clinical trials. It also assists in decision-making to determine the right therapy for patients, including personalized medicines. This makes drug development procedures cost-effective, faster, and more productive.With many other momentous innovations, the drug delivery market is expected to grow at a CAGR of 5.9 percent by 2026 to reach $2206.5 billion.To put the spotlight on other key developments in the industry, MedTech Outlook illustrates how drug delivery solutions are being utilized to drive the next patient care evolution. This edition also features thought leadership articles from subject matter experts. Some of the exclusive insights are authored by Antoni Chan, MBChB, PhD, FRCP, Clinical Lead in Rheumatology, Royal Berkshire NHS Foundation Trust, UK; Singithi Chandrasiri, Deputy Chief Medical Officer and Group Director, Academic and Medical Services at Epworth.In this edition of MedTech Outlook, we also bring you the stories of top drug delivery solution providers. In the list, ApiJect Systems stands out with the idea that more injectable medications and vaccines should be efficiently filled and given to patients in single-dose prefilled injection devices using blow-fill-seal (BFS) technology. Equally commendable is Vivera Pharmaceuticals, which has global exclusivity to license the patented and patent pending TABMELT sublingual drug delivery system for pharmaceutical use.Through the following pages, we aim to shine a light on the innovative trends and latest developments in the drug delivery space. We would like to know your thoughts.AI is Paving the Way for Smart Drug DeliveryEDITORIALEditorial StaffJoe PhilipLaura PintoJoshua ParkerMerlin WatsonSarah FernandesGina ClumskyYenny TurnerTiffany Hayworth
< Page 5 | Page 7 >